Background: Obstructive sleep apnea (OSA) is claimed to affect more than 50% of hemodialysis patients. It is known that OSA increases cardiovascular risk in end-stage kidney disease (ESKD) patients and impairs the quality of life with cardiovascular mortality remaining the lea...
The Verdict
ClassificationLikely AI
ConfidenceHigh confidence
Analyzedtext
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/599bd781-9502-40e1-bc6b-2c73ed4dc894)